* Inari Medical Inc reported a quarterly adjusted loss of 9 cents per share for the quarter ended September 30, lower than the same quarter last year, when the company reported EPS of 5 cents. The mean expectation of fifteen analysts for the quarter was for a loss of 11 cents per share. Wall Street expected results to range from -18 cents to -2 cents per share.
* Revenue rose 21.4% to $153.39 million from a year ago; analysts expected $150.67 million.
* Inari Medical Inc's reported EPS for the quarter was a loss of 31 cents.
* The company reported a quarterly loss of $18.37 million.
* Inari Medical Inc shares had risen by 6.0% this quarter and lost 32.7% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by about 2.5% in the last three months.
* In the last 30 days, one analyst negatively revised an earnings estimate
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 11 "strong buy" or "buy," 5 "hold" and no "sell" or "strong sell."
* The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy"
Wall Street's median 12-month price target for Inari Medical Inc is $65.50 This summary was machine generated from LSEG data October 29 at 02:47 a.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2024 -0.11 -0.09 Beat
Jun. 30 2024 -0.15 -0.38 Missed
Mar. 31 2024 -0.20 -0.22 Missed
Dec. 31 2023 0.01 -0.08 Missed
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。